EU approves Sanofi's 6-in-1 vaccine for infants

04/22/2013 | Reuters · Fox Business

The European Commission has cleared Sanofi's 6-in-1 pediatric vaccine for infants starting at six weeks. The vaccine prevents hepatitis B, poliomyelitis, diphtheria, tetanus, pertussis and invasive infections caused by Haemophilus influenzae type B. The vaccine will be sold as Hexyon in Western Europe and as Hexacima in Eastern Europe.

View Full Article in:

Reuters · Fox Business

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD